MDT Medtronic PLC

P/E 21.05
Forward P/E 13.32
Price/Sales 2.801
Beta 0.597
Div Yield 0.0363%
Market Cap --

Company Analysis

Latest News

🔴 Medtronic PLC is trading 4.2% down today amid broad market weakness and technical pressure

Medtronic PLC is trading 4.2% down at $77.89 amid a broadly weaker equity market and ongoing technical pressure following its recent post-earnings run-up. •...

Medtronic buys SPR Therapeutics for $650M, adding temporary pain treatment

Medtronic buys SPR Therapeutics for $650M, adding temporary pain treatment

Medtronic will acquire private medical technology firm SPR Therapeutics for $650 million in upfront cash. SPR Therapeutics specializes in peripheral nerve...

Medtronic seeks FDA expansion for Hugo robot, targeting high-volume surgeries

Medtronic seeks FDA expansion for Hugo robot, targeting high-volume surgeries

Medtronic submitted 510(k) filings to the FDA to expand the approved uses for its Hugo robotic-assisted surgery (RAS) system. The company seeks new clearance...

🟢 Medtronic PLC is trading 5.4% up today on strongest revenue growth in a decade and dividend hike

Medtronic PLC is trading 5.4% up at $82.16, extending its post-earnings rally after reporting its strongest annual revenue growth in a decade. • The company...

🟢 Medtronic PLC is trading 4.6% up today after beating Q4 revenue estimates and posting its highest annual growth in 10 years

Medtronic PLC is trading 4.58% up at $77.13 after reporting fourth-quarter results that beat revenue expectations and delivered its highest annual revenue...

Medtronic Posts Its Best Revenue Growth in a Decade, but Can a Cautious Profit Outlook Sustain a 7% Rally?

Shares of Medtronic surged 7.4% to $79.20 in pre-market trading on June 3 after the medical-device giant delivered fiscal Q4 results that beat on revenue and...

🟢 Medtronic PLC is trading 7.4% up today after reporting strong FY26 results and an earnings beat

Medtronic PLC is trading 7.4% up at $79.20 after reporting strong fiscal 2026 results and an earnings beat. • The company achieved its best annual revenue...

Medtronic beats fourth quarter estimates, delivering its highest annual revenue growth in 10 years for fiscal 2026.

Medtronic beats fourth quarter estimates, delivering its highest annual revenue growth in 10 years for fiscal 2026.

Medtronic reported fourth quarter revenue of $9.8 billion and non-GAAP EPS of $1.55, exceeding analyst expectations. For the full fiscal year 2026, the company...

Medtronic PLC Q4 2026 Earnings Preview: What Analysts Expect on June 03, 2026

Medtronic is projected to report fiscal fourth-quarter revenue of $9.62 billion and earnings per share of $1.54, with the current stock price of $73.73 trading...